Metraipolis › archive › dc_4891c3719fec

Safety and efficacy of SGLT2i administration in dilated cardiomyopathy: protocol for a systematic review and meta-analysis — Europe PMC PMID:41019438

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41019438
DOI
10.3389/fcvm.2025.1575493
License (as archived)
solo-consultazione
Archived
2026-11-09T23:53:26.909Z
SHA-256 of the archived text
0b00fe2fc5446e327d2b0bf30570b885c19f86c51639bcc07574714a832b9935
Stable URL of this page
https://metraipolis.com/documento/dc_4891c3719fec

How to cite

Safety and efficacy of SGLT2i administration in dilated cardiomyopathy: protocol for a systematic review and meta-analysis — Europe PMC PMID:41019438 — Europe PMC (en), https://europepmc.org/article/MED/41019438 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_4891c3719fec (Metraipolis archive dc_4891c3719fec, sha256 0b00fe2fc5446e327d2b0bf30570b885c19f86c51639bcc07574714a832b9935)
BibTeX
@misc{dc4891c3719fec,
  title = {Safety and efficacy of SGLT2i administration in dilated cardiomyopathy: protocol for a systematic review and meta-analysis — Europe PMC PMID:41019438},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41019438},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_4891c3719fec; sha256 0b00fe2fc5446e327d2b0bf30570b885c19f86c51639bcc07574714a832b9935},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41019438. Agents can read the archived copy with the MCP tool read_document.